You just read:

Longeveron LLC Announces Completion of Enrollment in Phase 1 Clinical Trial of Longeveron Allogeneic Mesenchymal Stem Cells (LMSCs) in Alzheimer's Disease

News provided by

Longeveron LLC

Dec 20, 2019, 13:00 ET